Brachytherapy induced volumetric changes of the left liver lobe after interstitial high dose rate brachytherapy of the right liver lobe (BRAVO)

Brachytherapy induced volumetric changes of the left liver lobe after interstitial high dose rate brachytherapy of the right liver lobe (BRAVO) - BRAVO

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011306

Enrollment

Registered

2017-03-15

Start date

2016-11-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.0 C78.7

Interventions

Group 1: patients with liver malignancy limited to liver seg IV – VIII undergoing interst. HDR Brachytherapy. Followed by an MRT based volumetry

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: liver malignancy limited to liver seg IV – VIII (additional malignancy seg II/III 30%, magnetic resonance imaging (MRI) of adequate quality before and after brachytherapy ( <3/ 3months, dependent on availability 6,9,12 months), one staged brachytherapy, primary and secondary liver malignancy

Exclusion criteria

Exclusion criteria: brachytherapy of the left liver lobe (seg.II,III), liver targeted therapy prior and 3 months post to AL, resection, prior Brachytherapy

Design outcomes

Primary

Measure	Time frame
MRI-Images to evaluate Volume changes seg. II/III; <3,3 dependent on availability 6,9,12 months	—

Secondary

Measure	Time frame
Liver volume changes	—

Countries

Germany

Contacts

Public ContactKonrad Mohnike

Klinik für Radiologie und NuklearmedizinUniversität Magdeburg

konrad.mohnike@med.ovgu.de+391-6713030

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026